Skip to main content

Advertisement

SpringerLink
Log in

Quality of care and outcomes in acute decompensated heart failure: The ADHERE registry

  • Published:
Current Heart Failure Reports Aims and scope Submit manuscript

Abstract

Despite 1 million or more annual hospitalizations, the management of acute decompensated heart failure remains largely empiric. Data are lacking regarding patient characteristics, usual comorbidities, commonly used treatment strategies, clinical outcomes, and adherence to recently published quality indicators. The Acute Decompensated Heart Failure National Registry (ADHERE®) has been established to capture data regarding the presentation, management, and expected outcomes of acute decompensated heart failure. The size of the registry and its web-based platform allow for evaluation of compliance with quality indicators, assessment of mortality risk, and correlation of parenteral treatment strategies with clinical outcomes. More than 100,000 patient episodes have been recorded in the registry. These patient data have been reviewed and reveal important findings regarding acute decompensated heart failure and potential opportunities to improve the quality of care.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Hunt SA, Baker D, Chin M, et al.: ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001, 38:2101–2113. These guidelines, developed by the American College of Cardiology and the American Heart Association, provide evidence-based recommendations to clinicians regarding the management of chronic HF.

    Article  PubMed  CAS  Google Scholar 

  2. Graves EJ, Kozak LJ: National hospital discharge survey: annual summary, 1996. Vital Health Stat 13 1999, 144:1–46.

    Google Scholar 

  3. American Heart Association, American Stroke Association: Heart Disease and Stroke Statistics—2004 Update. http:// www.americanheart.org/downloadable/heart/1072969766940HSStats2004Update.pdf. Accessed January 23, 2004

  4. Jong P, Vowinckel E, Liu PP, et al.: Prognosis and determinants of survival in patients newly hospitalized for heart failure: a population-based study. Arch Intern Med 2002, 162:1689–1694.

    Article  PubMed  Google Scholar 

  5. Aghababian RV: Acutely decompensated heart failure: opportunities to improve care and outcomes in the emergency department. Rev Cardiovasc Med 2002, 3(Suppl 4):S3-S9.

    PubMed  Google Scholar 

  6. Cohn JN, Tognoni G: Valsartan Heart Failure Trial Investigators: a randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001, 345:1667–1675.

    Article  PubMed  CAS  Google Scholar 

  7. Levy D, Kenchaiah S, Larson MG, et al.: Long-term trends in the incidence of and survival with heart failure. N Engl J Med 2002, 347:1397–1402.

    Article  PubMed  Google Scholar 

  8. Katz AM: Pathophysiology of heart failure: identifying targets for pharmacotherapy. Med Clin North Am 2003, 87:303–316.

    Article  PubMed  CAS  Google Scholar 

  9. Abraham WT, Lowes BD, Ferguson DA, et al.: Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure. J Card Fail 1998, 4:37–44.

    Article  PubMed  CAS  Google Scholar 

  10. Colucci WS, Elkayam U, Horton DP, et al.: Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. N Engl J Med 2000, 343:246–253.

    Article  PubMed  CAS  Google Scholar 

  11. Publication Committee for the VMAC Investigators: Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial. JAMA 2002, 287:1531–1540.

    Article  Google Scholar 

  12. Marcus LS, Hart D, Packer M, et al.: Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial. Circulation 1996, 94:3184–3189.

    PubMed  CAS  Google Scholar 

  13. Follath F, Cleland JG, Just H, et al.: Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study: efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised doubleblind trial. Lancet 2002, 360:196–202.

    Article  PubMed  CAS  Google Scholar 

  14. Jaski BE, Ha J, Denys BG, et al.: Peripherally inserted venovenous ultrafiltration for rapid treatment of volume overloaded patients. J Card Fail 2003, 9:227–231.

    Article  PubMed  Google Scholar 

  15. Aggarwal HK, Sumit, Nand N, et al.: Evaluation of role of acute intermittent peritoneal dialysis in resistant congestive heart failure. J Assoc Physicians India 2002, 50:1115–1119.

    PubMed  CAS  Google Scholar 

  16. Torre-Amione G, Young JB, Colucci WS, et al.: Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 2003, 42:140–147.

    Article  PubMed  CAS  Google Scholar 

  17. O’Connor CM, Gattis WA, Adams KF Jr, et al.: Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4). J Am Coll Cardiol 2003, 41:1452–1457.

    Article  PubMed  CAS  Google Scholar 

  18. Califf RM, Adams KF, McKenna WJ, et al.: A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: the Flolan International Randomized Survival Trial (FIRST). Am Heart J 1997, 134:44–54.

    Article  PubMed  CAS  Google Scholar 

  19. Cuffe MS, Califf RM, Adams KFJ, et al.: Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002, 287:1541–1547.

    Article  PubMed  CAS  Google Scholar 

  20. Shah MR, O’Connor CM, Sopko G, et al.: Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE): design and rationale. Am Heart J 2001, 141:528–535.

    Article  PubMed  CAS  Google Scholar 

  21. Fonarow GC, for the ADHERE Scientific Advisory Committee: The Acute Decompensated Heart Failure National Registry (ADHERE): opportunities to improve care of patients hospitalized with acute decompensated heart failure. Rev Cardiovasc Med 2003, 4(Suppl 7):S21-S30. This paper describes the rationale and design of ADHERE; opportunities to improve the management of ADHF with data derived from ADHERE are also presented.

    PubMed  Google Scholar 

  22. Wu AH, Parsons L, Every NR, Bates ER: Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002, 40:1389–1394.

    Article  PubMed  Google Scholar 

  23. Spencer FA, Meyer TE, Gore JM, Goldberg RJ: Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation 2002, 105:2605–2610.

    Article  PubMed  Google Scholar 

  24. Centers for Medicare and Medicaid Services: Medicare Quality Improvement Priorities. Version 1.0. Baltimore, MD: Centers for Medicare and Medicaid Services, US Department of Health and Human Services; 2003.

    Google Scholar 

  25. Joint Commission on Accreditation of Healthcare Organizations. http://www.jcaho.org/. Accessed January 9, 2004.

  26. Fonarow GC, Yancy CW, Chang SF, ADHERE Investigators: Variation in heart failure quality of care indicators among U.S. hospitals: analysis of 230 hospitals in the ADHERE registry [abstract 300]. J Card Fail 2003, 9(Suppl):S82.

    Article  Google Scholar 

  27. ADHERE Acute Decompensated Heart Failure National Registry: Second Quarter 2003 National Benchmark Report. http:// www.adhereregistry.com/national_BMR/index.html. Accessed February 3, 2004.

  28. Fonarow GC, Adams KF, Abraham WT, ADHERE Investigators: Risk stratification for in-hospital mortality in heart failure using classification and regression tree (CART) methodology: analysis of 33,046 patients in the ADHERE registry [abstract 290]. J Card Fail 2003, 9(Suppl):S79.

    Article  Google Scholar 

  29. Abraham WT, Adams KF, Fonarow GC, et al.: Comparison of inhospital mortality in patients treated with nesiritide vs. other parenteral vasoactive medications for acutely decompensated heart failure: an analysis from a large prospective registry database [abstract 298]. J Card Fail 2003, 9(Suppl 1):S81.

    Article  Google Scholar 

  30. Burger AJ, Horton DP, LeJemtel T, et al.: Effect of nesiritide (Btype natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J 2002, 144:1102–1108.

    Article  PubMed  CAS  Google Scholar 

  31. Burger AJ, Horton DP, Elkayam U, et al.: Nesiritide is not associated with the proarrhythmic effects of dobutamine in the treatment of decompensated CHF: the PRECEDENT study [abstract 178]. J Card Fail 1999, 5(Suppl 1):49.

    Article  Google Scholar 

  32. Silver MA, Horton DP, Ghali JK, Elkayam U: Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol 2002, 39:798–803.

    Article  PubMed  CAS  Google Scholar 

  33. Moskowitz R, Galvao M, Galvin C, et al.: Sex-based differences in patients hospitalized with acute decompensated heart failure [abstract 309]. J Card Fail 2003, 9(Suppl 1):S84.

    Article  Google Scholar 

  34. Yancy CW, Chang SF: Better outcomes in heart failure in African Americans despite negative risk factors: a report from the ADHERE Database [abstract 303]. J Card Fail 2003, 9(Suppl 1):S82.

    Article  Google Scholar 

  35. Peacock WF, Aponte J, Craig M, et al.: Predictors of unsuccessful treatment for congestive heart failure in the emergency department observation unit [abstract 465]. Acad Emerg Med 2003, 4:493–494.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Cardiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, 75390, Dallas, TX, USA

    Clyde W. Yancy MD

Authors
  1. Clyde W. Yancy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gregg C. Fonarow MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yancy, C.W., Fonarow, G.C. Quality of care and outcomes in acute decompensated heart failure: The ADHERE registry. Curr Heart Fail Rep 1, 121–128 (2004). https://doi.org/10.1007/s11897-004-0021-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11897-004-0021-8

Keywords

Search

Navigation